Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof

Abstract

The invention relates to plasminogen activator-1 (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or disorder associated with elevated PAI-1. The invention includes, but is not limited to, the use of such compounds to prevent or reduce thrombosis and fibrosis, to promote thrombolysis, and to modulate lipid metabolism and treat diseases or disorders associated with elevated PAI-1, cholesterol, or lipid levels.


Claims
CPC Classifications
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Aug 1, 2017
  • Application: Oct 31, 2013
    US US 201314439843 A
  • Priority: Oct 31, 2013
    US US 201314439843 A
  • Priority: Oct 31, 2013
    US US 2013/0067695 W
  • Priority: Oct 31, 2012
    US US 201261720838 P

Download Citation


Sign in to the Lens

Feedback